Companies: 10,795·Total market cap: $144.5T
CureVac N.V.

CureVac N.V.

CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio
52W High$5.72
52W Low$2.475

CureVac N.V. (CVAC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cvac · stock forecast · 8 analysts (3M) · FMP · updated Feb 10, 2026

Analyst Rating & Consensus

Based on 8 Wall Street analysts in the past 3 months

SellBuy

Hold

8 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
2
Hold
5
Sell
1
Strong Sell
0
Total: 8 · Buy rate: 25.0%

12-Month Price Target

High

$37.00

Consensus

$21.00

+350.6% upside

Low

$5.00

Median: $21 · Last Close: $4.66

The CureVac N.V. (CVAC) analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month CVAC price target is $21.00, representing +350.6% upside from the current price of $4.66.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $21 (350.6%)

Consensus Target

$21.00

350.6% upside

High Target

$37

694.0%

Low Target

$5

7.3%

Current Price

$4.66

as of today

Based on analyst price targets, the CVAC stock price prediction for the next 12 months ranges from $5 to $37. The consensus CVAC price forecast of $21.00 implies 350.6% upside from the current price of $4.66.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$4.660.10%

1-day model range: $4.63–$4.68. Peak: $4.68 (-0.10%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-46.9%
2028$2-60.6%
2029$2-66.2%
2030$1-68.9%
2031-70.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)40.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CVAC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.60BUY
MA 10$4.43BUY
MA 20$4.61BUY
MA 50$5.00SELL
MA 100$5.20SELL
MA 200$4.77SELL
Current $CVAC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.59BUY
EMA 10$4.54BUY
EMA 20$4.63BUY
EMA 50$4.89SELL
EMA 100$4.98SELL
EMA 200$4.78SELL
Current $CVAC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2025-06-26
Downgrade ↓
BuyNeutral
Jefferies2025-06-13
Downgrade ↓
BuyHold
JMP Securities2025-05-28
Maintains
Market OutperformMarket Outperform
UBS2025-04-30
Maintains
BuyBuy
JMP Securities2025-02-14
Maintains
Market OutperformMarket Outperform
JMP Securities2024-09-16
Maintains
Market OutperformMarket Outperform
JMP Securities2024-08-16
Maintains
Market OutperformMarket Outperform
JMP Securities2024-07-03
Maintains
Market OutperformMarket Outperform
Leerink Partners2024-04-25
Downgrade ↓
OutperformMarket Perform
Deutsche Bank2021-12-31
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on CureVac N.V. (CVAC) stock. Of the recent 18 rating actions, 0 were upgrades and 6 were downgrades. 8 analysts currently cover CVAC.

Analyst Recommendation Trends

Buy ratings101
Hold ratings02↑ +2
Sell ratings00

CVAC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$59M

↓ 56.9% YoY

Revenue Next Year

$85M

↑ 44.7% YoY

EPS This Year

$-0.49

EPS Next Year

$-0.42

↓ 13.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CVAC EPS of $-0.49 for the current fiscal year, based on estimates from 3 analysts. The CVAC revenue forecast is $59M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CVAC stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CVAC price target is $21.00 (+350.6% upside), with an analyst consensus of Hold.

The CVAC short-term stock prediction for tomorrow is $4.66 (-0.10%). The CVAC stock price prediction for 2027 estimates an average of $2. The CVAC stock prediction for 2030 projects a range of $1–$2.

CureVac N.V. trades on NASDAQ under the ticker CVAC. The CVAC stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 25% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CVAC forecast · 8 questions

According to 8 Wall Street analysts, the average 12-month CVAC price target is $21.00, with a high forecast of $37.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +350.6% potential upside from the current price of $4.66.

CVAC price targetWhat is CVAC price targetCVAC analyst price targetCVAC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.